FLUTE Cross-border Prostate Cancer Data Standard Guide
0.1.0 - ci-build
Funded by the European Union

FLUTE Cross-border Prostate Cancer Data Standard Guide, published by Flute Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/flute/ and changes regularly. See the Directory of published versions

Artifacts Summary

This page provides a list of the FHIR artifacts defined as part of this implementation guide.

Flute Project Prostate Cancer Models

Logical models representing the prostate cancer study variables

Inclusion Criteria for Prostate Cancer Cohorts

Criteria for including men in cohorts based on clinical suspicion of prostate cancer.

Prostate Cancer study Variables

Study variables for a study on prostate cancer.

Flute Project Prostate Cancer study variables Model Mappings

Model Mapping from the StudyVariables Logical models and this guide

Concept Map for Inclusion Criteria to FHIR

Concept map defining the inclusion criteria for prostate cancer cohorts, mapping study variables to FHIR resources.

Requirements to Study variables Model Map

Requirements to Study variables Model Map

Study variables Model to FHIR R4 Map

Study variables Model to this guide Map

Prostate Cancer Study variables

HL7 FHIR Profiles representing Prostate Cancer Study variables

FamilyMemberHistory: prostate cancer family history

A record detailing a patient's family history of prostate cancer.

Observation: PI-RADS

A risk assessment based on the PI-RADS (Prostate Imaging-Reporting and Data System) scoring system.

Observation: prostate specific antigen

Observation for the measurement of prostate specific antigen (PSA) levels in the blood.

Observation: prostate volume

Observation for measuring the volume of the prostate.

Procedure: biopsy

This profile represents the biopsy procedure performed on a patient.

Procedure: DRE

This profile represents the digital rectal examination (DRE) procedure performed on a patient.

Outcome Variable related to Prostate Cancer study

HL7 FHIR Profiles implementing outcome variable for Prostate Cancer study

Observation: Outcome BCN-RC 2

This profile represents the outcome for BCN-RC 2 ISUP-GG.

Knowledge Artifacts: Libraries

These define logic, asset collections and other libraries as part of content in this implementation guide.

Prostate Cancer Inclusion Criteria

Defines criteria for including patients in prostate cancer cohorts.

Prostate Cancer Research Variables

Retrieves key research variables for prostate cancer studies.

Structures: Questionnaires

These define forms used by systems conforming to this implementation guide to capture or expose data to end users.

Study variable Extraction

Study variable extractable questionnaire

Structures: Resource Profiles

These define constraints on FHIR resources for systems conforming to this implementation guide.

DocumentReference: link with variables

This profile described how to link an Image (or other kinds of 'documents' with the associated FLUTE variables.

ImagingStudy: link with variables

This profile described how to link an Imaging Study with the associated FLUTE variables.

Structures: Extension Definitions

These define constraints on FHIR data types for systems conforming to this implementation guide.

Resource supporting information

This extension provides a means to link the source resource to any target related information. This extension shall not be used when other more specific elements or standard extensions apply. E.g. Observation.hasMember.

Terminology: Value Sets

These define sets of codes used by systems conforming to this implementation guide.

DRE Observation Interpretation Codes

This ValueSet includes codes for interpreting the results of a digital rectal examination (DRE) in the context of prostate assessment.

Gleason Grade

Gleason Grade for Prostate Cancer

Malignant tumor of prostate Value Set

Malignant tumor of prostate.

Prostate Imaging – Reporting and Data System

Prostate Imaging – Reporting andData System (R)

Type of Biopsy

ValueSet for categorizing types of biopsy as initial or repeated

Testing Artifacts: TestPlans

These test plans are available to verify test coverage for this implementation guide

TestPlan for the populate of a questionnaire and extract of a questionnaireResponse

TestPlan for the populate of a questionnaire and extract of a questionnaireResponse for the study variable

Testing Artifacts: TestScripts

These test definitions are available to FHIR test engines to verify systems are conforming to this implementation guide

Study Inclusion Criteria - Scenario 01

This TestScript evaluates the inclusion criteria for patients participating in the study.

Study Inclusion Criteria - Scenario 02

This TestScript evaluates the inclusion criteria for patients participating in the study.

This TestScript is designed to validate the cql library ResearchVariables2

This TestScript is designed to validate the cql library ResearchVariables2 with an extract of a questionnaire response

This TestScript is designed to validate the extract of a questionnaire response

This TestScript is designed to validate the extract of a questionnaire response

This TestScript is designed to validate the populate of a questionnaire

This TestScript is designed to validate the populate of a questionnaire

Example: Example Instances

These are example instances that show what data produced and consumed by systems conforming with this implementation guide might look like.

EXP-S1-IncludedPatient

This bundle includes all the resources for a patient who has been included in the study.

EXP-S1-Patient

The Patient included in the study S1.

EXP-S2-ExcludedPatient

This bundle includes all the resources for a patient who has been excluded from the study.

EXP-S2-Patient

The Patient excluded in the study S2.

Questionnaire-StudyVariable-S1

The Questionnaire response for the Patient included S1.

Questionnaire-StudyVariable-S2

The Questionnaire response for the Patient excluded S2.